3 Stocks I Saw on T...
Health Care: Drugs
Endo Pharmaceutical Holdings Inc. (ENDP: NASDAQ)
$35.32 -0.54 | -1.52%
02/09/12 - 03:10 PM ET
985.19K / 1.42M
Vol / Avg. Vol:36.03 / 35.87
Open / Prev. Close:35.32 - 36.12
Today's Range:26.02 - 44.53
52 Wk Range:3.88%
Performance YTD:TheStreet Rating:
Portfolios with ENDP
- Portfolio NameUser Type
- ContributorTechnical Setups for the We...
- ContributorStocks Rising On Unusual Vo...
- ProBridgewater Associates
- ProD.E. Shaw
- ContributorBreakout Stocks Of The Week...
- ProChuck Royce - Royce & Assoc...
- ProJohn Hussman
- ContributorTechnical Setups for the We...
- ProZebra Capital
- UserMSCORE
Latest ENDP Headlines from TheStreet
- UBS: 6 Specialty Pharma Picks to Watch 01.21.12 | 07:01 am
- Endo Pharmaceutical Holdings Inc. (ENDP): Today's Featured Health Care Winner 12.12.11 | 04:12 pm
- 7 Stocks Rising on Unusual Volume 12.12.11 | 12:12 pm
- Endo Pharmaceuticals At 2011 Credit Suisse Annual Health Care Conference Call Transcript 11.11.11 | 02:11 pm
- Endo Pharmaceuticals Holdings' CEO Discusses Q3 2011 Results - Earnings Call Transcript 10.27.11 | 04:10 pm
- 2011 Consumer Recall Alerts 10.14.11 | 05:10 pm
- 5 Stocks With Relative Strength Poised to Break Out 09.30.11 | 02:09 pm
- Endo Pharmaceuticals Holdings CEO Discusses Q2 2011 Results - Earnings Call Transcript 08.09.11 | 01:08 pm
- 5 Stocks to Watch: Merck, RIM 04.29.11 | 07:04 am
- JB Hunt, Adtran: New Targets, Estimates 04.14.11 | 09:04 am
Press Releases for ENDP
- Endo Pharmaceuticals To Announce Fourth Quarter And Full Year 2011 Financial Results On February 24, 2012 - PR Newswire 02.03.12 | 08:02 am
- Endo Announces Potential Short-Term Supply Constraints Of Certain Analgesic Medications As A Result Of Temporary Shut Down Of Novartis Facility - PR Newswire 01.09.12 | 08:01 am
- BioDelivery Sciences Announces Worldwide License And Development Agreement With Endo Pharmaceuticals For BEMA Buprenorphine - PR Newswire 01.06.12 | 06:01 am
- Endo Pharmaceuticals And BioDelivery Sciences International Sign Licensing Agreement For BEMA Buprenorphine - PR Newswire 01.06.12 | 06:01 am
- Endo Pharmaceuticals To Present At J.P. Morgan 30th Annual Healthcare Conference - PR Newswire 12.27.11 | 09:12 am
- Endo Announces FDA Approval Of A New Formulation Of Opana® ER Designed To Be Crush-Resistant - PR Newswire 12.12.11 | 08:12 am
- Qualitest Pharmaceuticals Receives FDA Approval For Myzilra⢠Tablets (Levonorgestrel And Ethinyl Estradiol Tablets, USP), 0.05 Mg/0.03 Mg, 0.075 Mg/0.04 Mg, 0.125 Mg/0.03 Mg (28 - Day TriPhasic Regimen) - PR Newswire 11.28.11 | 04:11 pm
- Endo Pharmaceuticals To Present At The Bank Of America Merrill Lynch 2011 Leveraged Finance Conference - PR Newswire 11.23.11 | 08:11 am
- Endo Pharmaceuticals To Present At The Piper Jaffray Annual Healthcare Conference - PR Newswire 11.22.11 | 08:11 am
- Qualitest Pharmaceuticals Receives FDA Approval For Acetaminophen And Codeine Phosphate Oral Solution USP, 120mg/12mg Per 5mL - PR Newswire 11.14.11 | 08:11 am
Partner Headlines for ENDP
- Stocks To Watch This Week - Seeking Alpha 01.10.12 | 08:01 am
- Billionaire David Shaw's Favorite Stock Picks - Seeking Alpha 12.15.11 | 09:12 am
- Nupathe's Zelrix Going Down A Path With Multiple Headwinds - Seeking Alpha 12.09.11 | 09:12 am
- Questor Pharmaceuticals: Even In A Bad Market, Fantastic Growth Looks Attractive - Seeking Alpha 11.25.11 | 08:11 am
- Billionaire Ray Dalio's Q3 Portfolio Moves - Seeking Alpha 11.17.11 | 09:11 am
- Citigroup Releases Product and Pricing Trends for Endo Pharmaceuticals - Benzinga 11.07.11 | 09:11 am
- Strong Quarter at Endo Pharma - Analyst Blog - Zacks 10.28.11 | 04:10 pm
- Endo Pharma Ends Axomadol Deal - Analyst Blog - Zacks 08.18.11 | 07:08 pm
- Fifteen Health Care ETFs Trading Near 52-Week Highs - Benzinga 07.21.11 | 01:07 pm
- Endo's Back Pain Drug Disappoints - Analyst Blog - Zacks 07.01.11 | 05:07 pm
